G77S (p.Gly77Ser) variant of SV2A (Synaptic vesicle glycoprotein 2A)
G77S (p.Gly77Ser) in SV2A (Synaptic vesicle glycoprotein 2A) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes structural context.
G77S (p.Gly77Ser) variant details
- p.Gly77Ser
- NCI-TCGA Cosmic COSV1009
- cosmic curated COSV10097
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.268
- ESM-1b 0.00
- AlphaMissense 0.10
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available